Abstract
Delirium occurs in 20 - 50 % of hospitalized elderly patients. An age > 65 years is one of the factors predisposing to the development of delirium, which is a common syndrome in geriatric medicine. Two clinical guidelines on this condition were published in 2010: NICE clinical guideline 103, "Delirium: diagnosis, prevention, management" and the German guideline "S3-Leitlinie Analgesie, Sedierung und Delirmanagement in der Intensivmedizin". The article gives an overview of new aspects of delirium in the clinical context.
© Georg Thieme Verlag KG Stuttgart · New York.
MeSH terms
-
Aged
-
Analgesics, Opioid / adverse effects
-
Analgesics, Opioid / therapeutic use
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use
-
Cholinesterase Inhibitors / adverse effects
-
Cholinesterase Inhibitors / therapeutic use
-
Delirium / diagnosis
-
Delirium / etiology*
-
Delirium / prevention & control
-
Delirium / therapy
-
Drug Therapy, Combination
-
Germany
-
Hospitalization*
-
Humans
-
Hypnotics and Sedatives / adverse effects
-
Hypnotics and Sedatives / therapeutic use
-
Intensive Care Units
-
Phenylcarbamates / adverse effects
-
Phenylcarbamates / therapeutic use
-
Practice Guidelines as Topic
-
Risk Factors
-
Rivastigmine
Substances
-
Analgesics, Opioid
-
Antipsychotic Agents
-
Cholinesterase Inhibitors
-
Hypnotics and Sedatives
-
Phenylcarbamates
-
Rivastigmine